The coagulation system and angiogenesis Journal Article


Authors: Sidhu, G.; Soff, G. A.
Article Title: The coagulation system and angiogenesis
Abstract: In 1865, Armand Trousseau recognized the relationship between an activated coagulation system and malignancy [1]. He suggested that patients presenting with idiopathic venous thrombosis might be harboring an occult cancer. Numerous recent studies have also demonstrated an increased odds ratio of patients with idiopathic venous thromboembolic disease having an occult malignancy (i.e. [2]). Venous thromboembolic disease (VTE) is the second most common cause of death in cancer patients, after deaths from the underlying malignancy [3]. The prevalence of VTE depends on tumor type and treatment received. Recent studies note that activation of the coagulation system, in addition to predisposing to VTE, may also contribute directly to the growth of primary and metastatic cancers, in large part by promoting angiogenesis. In this chapter, we will review the role of platelets and the coagulation system in promoting tumor-associated angiogenesis. We will also discuss the effects of anticoagulation on angiogenesis and the effects of antiangiogenesis therapy on the coagulation system and risk of thrombosis. © 2009 Springer-Verlag US.
Keywords: thalidomide; review; angiogenesis inhibitor; bevacizumab; doxorubicin; fluorouracil; nonhuman; cancer patient; neoplasms; colorectal cancer; breast cancer; bleeding; neoplasm proteins; lung cancer; angiogenesis; neovascularization, pathologic; bladder cancer; risk assessment; thromboembolism; folinic acid; thrombosis; semaxanib; antiangiogenic therapy; warfarin; ovary carcinoma; heparin; anticoagulation; oxaliplatin; clinical trials, phase ii as topic; neovascularization, physiologic; angiogenesis inhibitors; artery thrombosis; thrombocytosis; low molecular weight heparin; thrombin; venous thromboembolism; anticoagulant agent; dalteparin; urokinase; angiostatin; fibrin; plasmin; thromboplastin; vitamin k group; blood clotting; thrombocyte function; uterus carcinoma; blood coagulation; blood coagulation factors; blood platelets; thrombophilia
Journal Title: Cancer Treatment and Research
Volume: 148
ISSN: 0927-3042
Publisher: Springer  
Date Published: 2009-01-01
Start Page: 67
End Page: 80
Language: English
DOI: 10.1007/978-0-387-79962-9_5
PUBMED: 19377919
PROVIDER: scopus
DOI/URL:
Notes: Chapter 5 in "Coagulation in Cancer" (ISBN: 978-0-387-79961-2) - "Export Date: 30 November 2010" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gerald A Soff
    93 Soff